Improvement of Implant Survival in Total Joint Arthroplasty of the Trapeziometacarpal Joint

Last updated: February 11, 2020
Sponsor: Regional Hospital Holstebro
Overall Status: Active - Recruiting

Phase

N/A

Condition

Osteoarthritis

Treatment

N/A

Clinical Study ID

NCT01554748
2012-01
  • Ages 18-80
  • All Genders

Study Summary

The study evaluates implant survival in total joint arthroplasty of the Trapeziometacarpal (TMC) joint by monitoring the survival of different implant types using radiostereometry (RSA) evaluation of the implants.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with Eaton type 2+3 TMC osteoarthritis

Exclusion

Exclusion Criteria:

  • Patients with Eaton type 4 TMC osteoarthritis

Study Design

Total Participants: 400
Study Start date:
January 01, 2008
Estimated Completion Date:
January 31, 2023

Study Description

The study evaluates implant survival and clinical outcome in total joint arthroplasty of the TMC joint. Different implant designs are included in the study both cemented and uncemented implants. Also the influence of patient factors and surgical technique on implant survival is investigated. The primary outcome is implant migration and loosening. Evaluation is done by monitoring migration and loosening of different implant types using RSA evaluation of the implants. Secondary outcomes are patient reported function evaluated with the Disability of the arm, shoulder and hand score (DASH) and visual analog pain score (VAS). Tertiary outcome is range of movement (ROM) plus grip strength.

Connect with a study center

  • Department of Orthopaedics, Regional Hospital Holstebro

    Holstebro, DK-7500
    Denmark

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.